Sumatriptan-d6 (succinate)
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Sumatriptan-d6 (succinate)
Description :
Sumatriptan-d6 succinate is the deuterium labeled Sumatriptan succinate. Sumatriptan succinate is an orally active 5-HT1 receptor agonist with Kis of 17 nM, 27 nM and 100 nM for 5-HT1D, 5-HT1B and 5-HT1A receptors, respectively. Sumatriptan succinate can be used for migraine headache research[1][2][3].Product Name Alternative :
GR 43175C-d6UNSPSC :
12352005Target :
5-HT Receptor; Isotope-Labeled CompoundsType :
Isotope-Labeled CompoundsRelated Pathways :
GPCR/G Protein; Neuronal Signaling; OthersField of Research :
Neurological DiseasePurity :
99.63Solubility :
H2O : 100 mg/mL (ultrasonic; warming)Smiles :
OC(CCCC(CC(O)=O)C(O)=O.C(CN(C([2H])([2H])[2H])C([2H])([2H])[2H])C=1C=2C(NC1)=CC=C(CS(NC)(=O)=O)C2Molecular Formula :
C18H21D6N3O6SMolecular Weight :
419.53References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]S J Peroutka, et al. Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites. Eur J Pharmacol. 1989 Apr 12;163 (1) :133-6. |[3]K L Dechant, et al. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1992 May;43 (5) :776-98.Shipping Conditions :
Blue IceStorage Conditions :
-20°C (Powder, sealed storage, away from moisture)Scientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedIsoform :
5-HT1 ReceptorCAS Number :
[1215621-31-0]

